Fidelity Investments’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Fidelity Investments’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,239,223	Closed	-$104M	–	5640
2023 Q2	$104M	Sell	2,239,223 -3,441,317	-61%	-$119M	0.01%	974
2023 Q1	$163M	Buy	5,680,540 +483,183	+9%	+$14.3M	0.01%	791
2022 Q4	$162M	Buy	5,197,357 +1,774,433	+52%	+$57.9M	0.02%	766
2022 Q3	$69.4M	Buy	3,422,924 +1,512,596	+79%	+$27.6M	0.01%	1099
2022 Q2	$29.6M	Buy	1,910,328 +1,569,206	+460%	+$27M	﹤0.01%	1486
2022 Q1	$6.53M	Sell	341,122 -51,478	-13%	-$919K	﹤0.01%	2288
2021 Q4	$9.94M	Sell	392,600 -571,900	-59%	-$16.8M	﹤0.01%	2116
2021 Q3	$31.6M	Buy	+964,500	New	+$32.8M	﹤0.01%	1627

Fidelity Investments's DICE Position: Q3 2023 in Review

Fidelity Investments sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 2,239,223 shares — an estimated $104M sold.

Fidelity Investments first reported a position in DICE in Q3 2021 and held it in 8 quarters. The position peaked at $163M in Q1 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Fidelity Investments reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Fidelity Investments sold 2,239,223 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $104M.
Fidelity Investments first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Fidelity Investments's DICE Therapeutics, Inc. Common Stock position peaked at $163M in Q1 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.